Brighton Jones’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
Other funds holding VNDA
ACM
Brighton Jones's VNDA Position: Q3 2026 in Review
Brighton Jones reduced its Vanda Pharmaceuticals (VNDA) stake by 60% in Q3 2026, selling an estimated $84.4K and leaving 10,379 shares worth $51K. The position accounts for ﹤0.01% of the portfolio, ranked #1357.
Brighton Jones first reported a position in VNDA in Q1 2026 and has held it in 3 quarters since. The position peaked at $160K in Q2 2026. 123 funds tracked by Wall St. Rank hold VNDA as of Q3 2026.
- Brighton Jones held 10,379 shares of Vanda Pharmaceuticals worth $51K as of Q3 2026.
- Brighton Jones sold 15,706 Vanda Pharmaceuticals shares in Q3 2026, an estimated $84.4K.
- Vanda Pharmaceuticals made up ﹤0.01% of Brighton Jones's portfolio in Q3 2026, its #1357 holding.
- Brighton Jones first reported a position in Vanda Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- Brighton Jones's Vanda Pharmaceuticals position peaked at $160K in Q2 2026.
- 123 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.